Juurdepääsetavus ja lugemismugavus

Teksti suurus

Hele/tume režiim

Ridade vertikaalne vahekaugus

Kas teil on probleeme meie veebisaidi kasutamisega?
Kontakt

Dr Claudia Priglinger

In Sellel leheküljel

Liikmete teave

Dr Claudia Priglinger

Esindaja

Saksamaa

meeskond

HCP keskus

LMU haigla oma kahe Müncheni objektiga, Campus Großhadern ja Campus Innenstadt, on üks suurimaid ülikoolihaiglaid Saksamaal ja...

kontakt

Klinikum der Universität München, Germany

Mathildenstraße 8
80336 Munich
Germany

Kliinilised uuringud

NCT03406104 Lõpetatud

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
NCT03364153 Lõpetatud

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche

NCT04435366 Lõpetatud

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
NCT04276558 Lõpetatud

Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
NCT04770545 Lõpetatud

A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
DRKS00023562 Värbamine, aktiivne

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
NCT01756456 Lõpetatud

Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
NCT05870566 Värbamine, aktiivne

UV Light-mediated Corneal Crosslinking as (Lymph)Angioregressive Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche
2020-000681-42 Värbamine, aktiivne

Long-term need of the drug ranibizumab applied as injection into the eye with or without early targeted peripheral laser photocoagulation of the retina for treatment of macular edema due to central retinal vein occlusion

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche

Evaluation der Wirksamkeit einer transkornealen Elektrostimulation bei Patienten mit Retinitis Pigmentosa - eine multizentrische, prospektive, randomisierte, kontrollierte und doppel-blinde Studie im Auftrag des Gemeinsamen Bundesausschusses (G-BA)

Interventsiooniline
Vaadake kohtuprotsessi
voir la fiche

Teaduslikud väljaanded

RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec

Phenotypic and Genetic Spectrum in 309 Consecutive Pediatric Patients with Inherited Retinal Disease

Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial

Deep Learning-Based Retinal Layer Segmentation in Optical Coherence Tomography Scans of Patients with Inherited Retinal Diseases

Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy

Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy